1 unit-dose vial (2.5 ml) Nebuliser solution contains (8r)-3α-hydroxy-8-isopropyl-1αH,5αH-tropanium bromide (±)-tropate monohydrate (= ipratropium bromide) corresponding to 0.5 mg ipratropium bromide anhydrous 520 mcg, di[(RS)-2-tert-butylamino-1-(4-hydroxy-3-hydroxymethyl-phenyl)ethanol] sulphate (= salbutamol sulphate) corresponding to 2.5 mg salbutamol base 3010 mcg.
Excipients/Inactive Ingredients: sodium chloride, hydrochloric acid, purified water.